CEO and President of Conavi Medical Novasight hybrid is the power of simultaneous ultrasound and optical imaging to help physicians see the whole picture.
Atlanta, Georgia
Joined December 2013
- Tweets265
- Following143
- Followers135
- Likes151
Thomas Looby retweeted
$CNVI.V $CNVIF
This quarter, #Conavi received the 'Best New Technology Solution– Imaging' Award for its next-generation hybrid #IVUS-#OCT imaging platform. 🫀
Thank you @MedTech_Awards for this recognition!
More details 🔗 medtechbreakthrough.com/2026…
#MedTech #IntravascularImaging #HealthcareInnovation
Thomas Looby retweeted
New @MyJSCAI publication analyzed 25 studies across multiple countries...
When evaluated over a patient’s lifetime, #IntravascularImaging not only improves outcomes significantly, but is cost-effective and often cost-saving, reducing adverse events and repeat interventions.
Increases number of #PCI procedures, clinical evidence, guideline support, and adoption of IVI, understanding its long-term economic impact has become increasingly important.
Read more on the publication here 🔗 lnkd.in/etsiwkGD
$CNVI.V $CNVIF @SCAI #Conavi
Thomas Looby retweeted
$CNVI.V $CNVIF
Please welcome Mark Quick to our leadership team as CFO.
With 20+ years in U.S. #medtech and #lifesciences finance, he joins #Conavi at a pivotal moment for next-gen #Novasight, helping prepare for a successful U.S. launch and expand our presence in the world’s largest #intravascularimaging market.
Thank you to Stefano Picone, who has been instrumental in Conavi’s growth over the past decade. We’re excited he’ll continue to guide our strategy and support this next phase.
🔗Full #CNVI release: tinyurl.com/MQuickCNVI
Thomas Looby retweeted
Yesterday @TCTConference 📸
🔹Dr. Gary Mintz & Dr. Evelyn Regar presented #HybridImaging in a #stentthrombosis ACS case.
🔹Dr. Khady Fall & Dr. Akiko Maehara showcased a complex #calcifiedcase.
Don't miss today's Intravascular Imaging & Training lineup at #TCT2025 👇
Thomas Looby retweeted
@ConaviMed CEO @ThomasLooby breaks down the development & future of the Novasight Hybrid System—manufactured by @minnetronix— in @MedTechVoice's latest Viewpoints column. A great spotlight on next-gen innovation.
Read more: medtechintelligence.com/view…
Thomas Looby retweeted
We are proud to share that our work with @ConaviMed on the Novasight Hybrid™ System has earned a 2025 @MSPBJnews #Minnesota Manufacturing Award for Product Innovation! We are honored to help bring this groundbreaking tech to life in St. Paul.
bizjournals.com/twincities/n…
Thomas Looby retweeted
🚨New Episode! Med Tech Gurus 🚨
Discover how @ConaviMed is transforming cardiac care with advanced imaging tech.🫀
"Seeing the Heart Like Never Before" - a deep dive into innovation, precision, and saving lives. 🎧
Listen to the full episode now: traffic.libsyn.com/med-tech-…
#MedTech #Cardiology #Innovation #Podcast $CNVI $CNVIF
So proud to lead the team that raised C$20M to commercialize @ConaviMed’s next-gen interventional #cardiology imaging technology.
Thanks to Bloom Burton & Co. for making it happen!
We've closed a C$20M financing led by Bloom Burton & Co., with support from strategic US healthcare investors. Huge thanks to our amazing team & partners!
Read more: globenewswire.com/news-relea…
#Cardiology #MedTech #ImageFirst #InterventionalCardiology #BloomBurton
$CNVI.V $CNVIF
Great things happen when product innovation meets market readiness! While EU and US guidelines have risen to 1A for certain patient populations, @ConaviMed has been busy perfecting its Novasight Hybrid system which combines #IVUS and #OCT within a single catheter. $CNVI.V $CNVIF
New U.S. intravascular imaging guidelines are highly encouraging… they cite both #IVUS and #OCT as the standard of care for key procedures. More than ever, our value proposition speaks to patients, doctors, payers and hospital administrators $CNVI.V $CNVIF #ImageFirst
lnkd.in/eBzVJVfw
Thomas Looby retweeted
New U.S. intravascular imaging guidelines are highly encouraging… they cite both #IVUS and #OCT as the standard of care for key procedures. More than ever, our value proposition speaks to patients, doctors, payers and hospital administrators $CNVI.V $CNVIF #ImageFirst
lnkd.in/eBzVJVfw
I'm excited to share @ConaviMed's Shareholder Update and 2025 Outlook -- we're looking forward to a transformative year!
As we enter 2025, we're well positioned to set a new imaging standard for the most common procedures in interventional #cardiology -- learn more in our Shareholder Update and 2025 Outlook $CNVI.V $CNVIF globenewswire.com/news-relea…(the,Novasight%20Hybrid%E2%84%A2%20System%20intellectual
Thomas Looby retweeted
As we enter 2025, we're well positioned to set a new imaging standard for the most common procedures in interventional #cardiology -- learn more in our Shareholder Update and 2025 Outlook $CNVI.V $CNVIF globenewswire.com/news-relea…(the,Novasight%20Hybrid%E2%84%A2%20System%20intellectual
Thomas Looby retweeted
The January issue of @MedicalBriefs features an article by @minnetronix's Darcy Hart & @ThomasLooby from @ConaviMedical! Learn how their innovative cardio imaging device combines two modalities into one system to improve patient care:
tinyurl.com/42hhkmtn
Thomas Looby retweeted
Understand why our hybrid coronary imaging platform is a significant advance for interventional cardiologists, patients, and administrators – this recent @MedicalBriefs article lays out the thinking behind our no-compromise Novasight solution.
Written in #collaboration with @Minnetronix, a world leader in high-precision medical device manufacturingmedicaldesignbr… $CNVI.V $CNVIF
Excited to have this article published by @MedicalBriefs. @ConaviMed and @minnetronix have designed the future of cardiovascular imaging by combining IVUS and OCT into a single catheter.
Cardio Imaging Device Combines Two Modalities into Single System disq.us/t/4sjby69
Delighted to co-author a deep-dive into Conavi’s collaboration with the terrific team at @Minnetronix
Learn how we’re building the next generation of cardiovascular imaging technology in #collaboration with U.S.-based @Minnetronix, a world leader in high-precision medical device manufacturing medicaldesigndevelopment.com… $CNVI.V $CNVIF
Thomas Looby retweeted
Our CEO, @ThomasLooby, will be presenting on Dec 11th, 2024 at the MedInvest MedTech, AI & Digital Health Conference in New York City $CNVI $CNVIF
globenewswire.com/news-relea…
Thanks to the hard work of our partner in China as well as our team at Conavi Medical. Your efforts have made it possible for us to achieve this important milestone! $CNVI $CNVIF
Congratulations to our partner in China, which has received NMPA approval for a version of the Novasight Hybrid system as part of a licensing arrangement $CNVI $CNVIF
lnkd.in/eH3ud2xE
Thomas Looby retweeted
Thomas Looby, CEO, @ConaviMed (TSXV:CNVI), and his team, joined us to open the market to celebrate the Company’s new listing on TSX Venture Exchange.
$CNVI is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. The Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration; and regulatory approval for clinical use from Health Canada, China’s National Medical Products Administration, and Japan’s Ministry of Health, Labor and Welfare. For more information, visit conavi.com/
Thomas Looby retweeted
Check out today's @BioTuesdays feature article on Conavi Medical and our #hybrid #IVUS #OCT imaging platform!
biotuesdays.com/2024/11/05/c…